Xenon Pharmaceuticals: Strategic Advancements and Promising Clinical Developments Earn a Buy Rating
H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on Xenon (XENE – Research Report) today and set a price target of $53.00.
Business Wire22h
With 78% of SMBs Embracing AI, Picsart Launches New Logo Maker Enabling Anyone to Create Standout Logos in Minutes
LISBON, Portugal--(BUSINESS WIRE)--Picsart, with over 100 million monthly users, has launched an AI-powered Logo Maker tailored to small businesses, solopreneurs, and side hustlers. Designed for ...